Sernova Biotherapeutics Inc SVA.TO
TSX
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.43M | -8.64M | -8.89M | -11.21M | -13.27M |
| Total Depreciation and Amortization | 54.40K | 185.90K | 216.20K | 246.50K | 326.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.62M | 2.29M | 1.92M | 1.97M | 833.20K |
| Change in Net Operating Assets | 1.56M | 2.17M | 1.67M | 1.27M | 1.63M |
| Cash from Operations | -3.20M | -4.00M | -5.09M | -7.73M | -10.48M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 14.50K | 18.00K | 18.00K | 18.00K | 3.50K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | 14.50K | 18.00K | 18.00K | 18.00K | 3.50K |
| Total Debt Issued | 1.58M | 1.75M | 4.94M | 4.94M | 4.84M |
| Total Debt Repaid | -4.01M | -4.03M | -70.40K | -112.90K | -148.10K |
| Issuance of Common Stock | 6.82M | 6.82M | 1.55M | 266.90K | 5.21M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -18.20K | -18.20K | 58.40K | 46.60K | -188.70K |
| Cash from Financing | 3.18M | 3.29M | 4.59M | 3.62M | 6.98M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.00K | -690.20K | -482.20K | -4.09M | -3.49M |